Pearl River Capital, LLC Natera, Inc. Transaction History

Pearl River Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$37.55 - $62.64 $159,587 - $266,220	-4,250 Reduced 28.47%	10,677 $668,000
Q3 2023 Nov 13, 2023	SELL	$43.4 - $62.52 $59,892 - $86,277	-1,380 Reduced 8.46%	14,927 $660,000
Q2 2023 Aug 11, 2023	BUY	$47.08 - $55.16 $767,733 - $899,494	16,307 New	16,307 $793,000
Q2 2020 Aug 10, 2020	SELL	$26.36 - $49.86 $817 - $1,545	-31 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$17.27 - $40.17 $535 - $1,245	31 New	31 $1,000
Q1 2019 May 02, 2019	SELL	$11.34 - $20.62 $13,914 - $25,300	-1,227 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$12.32 - $24.38 $15,116 - $29,914	1,227 New	1,227 $17,000

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.